Kenvue Inc.

$23.65
(as of May 30, 9:31 AM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Kenvue Inc.

Stock Price
$23.65
Ticker Symbol
KVUE
Exchange
NYSE

Industry Information for Kenvue Inc.

Sector
Consumer Defensive
Industry
Household & Personal Products

Company Description for Kenvue Inc.

Country
USA
Full Time Employees
22,000

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Fundamentals for Kenvue Inc.

Market Capitalization
$45,213,880,320
EBITDA
$3,508,999,936
Dividends per Share
$0.82
P/E Ratio
42.05
Forward P/E Ratio
20.62
Earnings per Share
$0.56
Earnings per Share Estimate Next Year
Profit Margin
6.90%
Shares Outstanding
1,919,910,016
Percent Owned by Insiders
0.04%
Percent Owned by Institutions
101.04%
52-Week High
52-Week Low

Technical Indicators for Kenvue Inc.

50-Day Moving Average
200-Day Moving Average
RSI
54.25
0.55

Analyst Ratings for Kenvue Inc.

Strong Buy
3
Buy
2
Hold
14
Sell
0
Strong Sell
0

News About Kenvue Inc.

May 30, 2025, 3:00 PM EST
[Stock market Exchanges Volume Leaders Digital Tableau interface background] See more.
May 29, 2025, 2:04 PM EST
Below is Validea's guru fundamental report for KENVUE INC (KVUE). See more.
May 21, 2025, 6:45 AM EST
SUMMIT, N.J., May 21, 2025--(BUSINESS WIRE)--Kenvue Inc. See more.
May 18, 2025, 4:16 PM EST
Daniel Loeb’s hedge fund, Third Point, has taken a significant position in Kenvue Inc. See more.